# Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)

> **NCT02257216** · NA · COMPLETED · sponsor: **Enzymotec** · enrollment: 171 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder (ADHD)

## Interventions

- **OTHER:** Vayarin®
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02257216
- **Lead sponsor:** Enzymotec
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2017-05
- **Final completion:** 2017-06
- **Target enrollment:** 171 (ACTUAL)
- **Last updated:** 2018-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02257216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02257216, "Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02257216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*